https://www.zonebourse.com/cours/action/SANOFI-4698/actualite/Point-d-actualite-sur-le-programme-de-phase-III-relatif-a-Dupixent-dupilumab-dans-le-traitem-39510553/?utm_source=telegram&utm_medium=social&utm_campaign=share